Overview

Contrast Enhanced Endoscopic Ultrasound in Pancreas Lesions

Status:
Recruiting
Trial end date:
2022-02-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether quantitative contrast-enhanced endoscopic ultrasound (CE-EUS) improves the evaluation of pancreas tumors and precursor lesions, including cysts, compared to conventional endoscopic ultrasound.
Phase:
Phase 1
Details
Lead Sponsor:
Cedars-Sinai Medical Center
Treatments:
Pancreatin
Pancrelipase